Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.12.23 | Britannia Life Sciences Inc: Britannia Life's ADSL establishes U.S. division | 1 | Stockwatch | ||
18.12.23 | Britannia Life Sciences Inc: Britannia Establishes U.S. Consumer Products Division | 352 | Newsfile | New cosmetic product safety regulations in the U.S. will usher in more stringent compliance and reporting requirements ADSL to initially offer U.S. clients access to its technology-enabled safety and... ► Artikel lesen | |
12.12.23 | Britannia Life Sciences Inc: Britannia names Bowes-Cavanagh global consumer CEO | 1 | Stockwatch | ||
12.12.23 | Britannia Life Sciences Inc: Britannia Life Sciences Appoints Mark Bowes-Cavanagh to Lead Growth of Global Consumer Products Division | 451 | Newsfile | Mark-Bowes-Cavanagh has been appointed Chief Executive Officer of Britannia's growing global consumer compliance and regulatory businessMr. Bowes-Cavanagh will continue in his role as Chief Technical... ► Artikel lesen | |
11.12.23 | Britannia Life Sciences Inc: Britannia Life launches Green Bridge partnership | 1 | Stockwatch | ||
11.12.23 | Britannia Life Sciences Inc: Britannia Life Sciences Joins Forces with the ACI and ChemID to Facilitate UK CBD Market Access | 147 | Newsfile | Through its subsidiary, ADSL, Britannia will provide a variety of analytical and regulatory compliance services to the ACI's Green Bridge Gateway. Strategic partnership provides UK CBD market access... ► Artikel lesen | |
29.11.23 | Britannia Life Sciences Inc: Britannia Life omits Q2 P&L in NR, talks revenue | 1 | Stockwatch | ||
29.11.23 | Britannia Life Sciences Inc. Announces Second Quarter Results | 245 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 29, 2023) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to provide its unaudited financial results for... ► Artikel lesen | |
06.11.23 | Britannia Life Sciences Inc: Britannia Provides Update on Mining Division Including Britannia Mining Solutions and Paragon Geochemical | 341 | Newsfile | Britannia Mining Solutions is a partially owned subsidiary of Britannia Life SciencesBritannia Mining Solutions owns Paragon Geochemical, a full-service, state-of-the-art lab in Sparks, Nevada providing... ► Artikel lesen | |
29.08.23 | Britannia Life Sciences Inc. Announces First Quarter Results | 377 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 29, 2023) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to provide its unaudited financial results for... ► Artikel lesen | |
01.08.23 | Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results | 316 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 1, 2023) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to provide its financial results for the year ended March 31... ► Artikel lesen | |
06.06.23 | Britannia Life Sciences Inc: Britannia Life Sciences Announces Strategic Investment in Cosmetics Lab Ltd. | 490 | Newsfile | Cosmetics Lab is a U.K.-based service provider to the cosmetics industry offering a full range of new product development support and advanced manufacturing servicesBroadens Britannia's already robust... ► Artikel lesen | |
05.06.23 | Britannia Life Sciences Inc: Britannia Mining Solutions Accelerates Lab Build-Out Plan with Strategic Acquisition of Paragon Geochemical Laboratories Inc. | 428 | Newsfile | Paragon operates an industry-leading geochemistry lab strategically located near Reno, Nevada, at the heart of one of the world's most active mining regionsFast-tracks Britannia's entry into the minerals... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 51,90 | +1,37 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
FRESENIUS | 27,950 | -0,07 % | Fresenius mit Verkauf: Wachstum des Kerngeschäfts im Fokus - Aktie zieht weiter an | Fresenius kommt bei seiner Neuausrichtung weiter voran. Wie der Gesundheitskonzern am Donnerstagabend mitgeteilt hat, soll das Vamed-Reha-Geschäft veräußert werden. Fresenius werde aber ein Drittel... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 39,260 | -2,34 % | Kursgewinne für die Aktie von Fresenius Medical Care (38,13 €) | Im deutschen Wertpapierhandel liegt der Anteilsschein von Fresenius Medical Care aktuell im Plus. Das Wertpapier kostete zuletzt 38,13 Euro. Freuen können sich gegenwärtig die Aktionäre von Fresenius... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 64,31 | +4,16 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
CARL ZEISS MEDITEC | 97,80 | +0,46 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 3,330 | -84,91 % | Mobile-health Retreats on Opening New Pharmacy | ||
RXSIGHT | 61,68 | +3,44 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
ATRICURE | 20,890 | -5,99 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
GERRESHEIMER | 102,00 | +0,39 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen | EQS-News: Gerresheimer AG
/ Schlagwort(e): Vertrag/Beteiligung/Unternehmensbeteiligung
Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen
29.04.2024... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,740 | +1,79 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 11,500 | +3,98 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
CASTLE BIOSCIENCES | 24,330 | +6,52 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen | |
ADAPTHEALTH | 10,260 | -0,87 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 6,630 | +26,05 % | Alignment Healthcare Reports First Quarter 2024 Results | Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectivelyMedicare Advantage membership grows 50.5% year-over-year to... ► Artikel lesen | |
MIMEDX | 7,370 | -1,73 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen |